Trulieve Cannabis Corp. (NYSE:TRLV – Get Free Report) CEO Kim Rivers sold 204,815 shares of the stock in a transaction dated Monday, June 22nd. The stock was sold at an average price of $9.35, for a total value of $1,915,020.25. Following the transaction, the chief executive officer owned 2,693,724 shares of the company’s stock, valued at approximately $25,186,319.40. This trade represents a 7.07% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Trulieve Cannabis Price Performance
Shares of Trulieve Cannabis stock opened at $9.21 on Tuesday. Trulieve Cannabis Corp. has a one year low of $3.25 and a one year high of $13.28.
Wall Street Analyst Weigh In
Separately, Weiss Ratings began coverage on Trulieve Cannabis in a research report on Tuesday, June 16th. They set a “sell (d-)” rating for the company. One investment analyst has rated the stock with a Sell rating, According to MarketBeat, the stock has an average rating of “Sell”.
Trulieve Cannabis Company Profile
Trulieve Cannabis Corp. is a vertically integrated cannabis company focused on the cultivation, processing, and retail sale of medical and adult-use cannabis products. The company offers a range of products that may include flower, pre-rolls, concentrates, edibles, vape products, and topicals through its dispensary network and branded product portfolio.
Trulieve’s operations have been centered primarily in the United States, with a strong presence in Florida and additional markets in other states where cannabis is legally regulated.
Read More
- Five stocks we like better than Trulieve Cannabis
- Buy CrowdStrike Before the Stock Split? Here’s the Case
- Investors Are Buying Into Sweetgreen Again—Should They?
- Burlington Is Winning Over Shoppers But Investors Need Patience
- USA Today’s Digital Revival Is Gaining Steam, But With Plenty of Risk
Receive News & Ratings for Trulieve Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trulieve Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.
